Prelude Therapeutics News

Prelude Therapeutics | 8-K: Current report

Sep 9 21:05

Prelude Therapeutics | 8-K: Prelude Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 19:15

Prelude Therapeutics | 8-K: Current report

Jun 19 04:13

Prelude Therapeutics | 8-K: Current report

Jun 12 19:01

Prelude Therapeutics | S-3: Registration statement for specified transactions by certain issuers

May 31 04:35

Prelude Therapeutics | 8-K/A: Current report (Amendment)

May 17 04:12

Prelude Therapeutics | 8-K: Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 7 19:14

Prelude Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

May 7 04:30

Prelude Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:28

Prelude Therapeutics | DEFA14A: Others

Apr 27 04:25

Prelude Therapeutics | 8-K: Current report

Apr 11 04:10

Prelude Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Feb 17 01:58

Prelude Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 17 01:58

Prelude Therapeutics | 8-K: Current report

Feb 16 05:26

Prelude Therapeutics | 8-K: Current report

Dec 11, 2023 22:17

Prelude Therapeutics | 8-K: Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results

Nov 2, 2023 04:23

Prelude Therapeutics | 8-K: Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Aug 3, 2023 20:10

Prelude Therapeutics | 8-K: Current report

Jun 22, 2023 04:05

Prelude Therapeutics | 8-K: Current report

Jun 2, 2023 04:25

Prelude Therapeutics | 8-K: Current report

May 20, 2023 04:06